All News about Akero Therapeutics Inc![]() ![]() ![]() ![]() ![]() ![]()
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
September 14, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
Via Benzinga
![]()
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
December 08, 2022
From Akero Therapeutics
Via GlobeNewswire
![]() From Akero Therapeutics
Via GlobeNewswire
![]() ![]()
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|